Astellas Pharma US
Astellas Pharma US, Inc.
2375 Waterview Drive
Northbrook, IL 60062
Phone: (800) 727-7003Website: https://www.astellas.com/us/Careers: astellascareers.jobsPatient Assistance Program: astellaspharmasupportsolutions.com...
Latest news
- U.S. FDA Approves Padcev plus Keytruda or Keytruda Qlex as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
July 10, 2026 - U.S. FDA Approves Expanded Label for Astellas' Izervay (avacincaptad pegol intravitreal solution) for Geographic Atrophy
February 12, 2025 - FDA Approves Vyloy (zolbetuximab-clzb) for the Treatment of Advanced Gastric and GEJ Cancer
October 21, 2024 - FDA Adds Warning About Rare Occurrence of Serious Liver Injury with Use of Veozah (fezolinetant) for Hot Flashes Due to Menopause
September 12, 2024 - U.S. FDA Acknowledges Astellas' Resubmission of Biologics License Application for Zolbetuximab and Sets New Action Date
May 30, 2024 - Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide
January 26, 2024 - Astellas Provides Update on Zolbetuximab Biologics License Application in U.S.
January 8, 2024 - Padcev (enfortumab vedotin-ejfv) with Keytruda (pembrolizumab) Approved by FDA as the First and Only ADC Plus PD-1 to Treat Advanced Bladder Cancer
December 15, 2023 - FDA Approves Expanded Use of Cresemba (isavuconazonium sulfate) in Children with Invasive Aspergillosis and Invasive Mucormycosis
December 8, 2023 - Pfizer and Astellas' Xtandi Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting
November 16, 2023
Drugs Associated with Astellas Pharma US, Inc.
Astellas Pharma US, Inc. manufactures, markets and/or distributes more than 15 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
AmBisome
Generic name: amphotericin b liposomal Drug class: polyenes |
||
|
Astagraf XL
Generic name: tacrolimus Drug class: calcineurin inhibitors |
||
|
Cresemba
Generic name: isavuconazonium Drug class: azole antifungals |
2 reviews | 4.7 / 10 |
|
Izervay
Generic name: avacincaptad pegol Drug class: anti-angiogenic ophthalmic agents |
3 reviews | 8.9 / 10 |
|
Lexiscan
Generic name: regadenoson Drug class: cardiac stressing agents |
36 reviews | 6.0 / 10 |
|
Mycamine
Generic name: micafungin Drug class: echinocandins |
||
|
Myrbetriq
Generic name: mirabegron Drug class: urinary antispasmodics |
276 reviews | 4.9 / 10 |
|
Padcev
Generic name: enfortumab vedotin Drug class: miscellaneous antineoplastics |
2 reviews | 1.0 / 10 |
|
Prograf
Generic name: tacrolimus Drug class: calcineurin inhibitors |
28 reviews | 8.1 / 10 |
|
Veozah
Generic name: fezolinetant Drug class: miscellaneous central nervous system agents |
40 reviews | 7.4 / 10 |
|
VESIcare
Generic name: solifenacin Drug class: urinary antispasmodics |
142 reviews | 5.5 / 10 |
|
VESIcare LS
Generic name: solifenacin Drug class: urinary antispasmodics |
||
|
Vyloy
Generic name: zolbetuximab Drug class: miscellaneous antineoplastics |
||
|
Xospata
Generic name: gilteritinib Drug class: multikinase inhibitors |
1 review | 8.0 / 10 |
|
Xtandi
Generic name: enzalutamide Drug class: antiandrogens, hormones/antineoplastics |
21 reviews | 6.9 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||